Catalyst Pharmaceutical

Catalyst to ax 30% of workforce in wake of FDA trial demands

Catalyst Pharmaceuticals is having to tighten its belt and cut nearly a third of its staff in order to retain enough cash to undertake new studies for its key drug Firdapse.

Ben Adams May 17, 2016 9:10am

Catalyst Pharmaceuticals hit by FDA extra studies request for Firdapse

Apr 26, 2016 9:05am